Cite
Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection.
MLA
Gabutti, G., et al. “Immunogenicity and Reactogenicity Following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus Influenzae Type B Vaccine Administered by Separate or Mixed Injection.” Clinical Drug Investigation, vol. 25, no. 5, May 2005, pp. 315–23. EBSCOhost, https://doi.org/10.2165/00044011-200525050-00004.
APA
Gabutti, G., Bona, G., Dentico, P., Bamfi, F., Hardt, K., Majori, S., & Crovari, P. (2005). Immunogenicity and Reactogenicity following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus influenzae Type B Vaccine Administered by Separate or Mixed Injection. Clinical Drug Investigation, 25(5), 315–323. https://doi.org/10.2165/00044011-200525050-00004
Chicago
Gabutti, G., G. Bona, P. Dentico, F. Bamfi, K. Hardt, S. Majori, and P. Crovari. 2005. “Immunogenicity and Reactogenicity Following Primary Immunisation with a Combined DTaP-HBV Vaccine and a Haemophilus Influenzae Type B Vaccine Administered by Separate or Mixed Injection.” Clinical Drug Investigation 25 (5): 315–23. doi:10.2165/00044011-200525050-00004.